Heterogeneity in the genetic basis of human complement C9 deficiency

Immunogenetics

Volumn 48, Issue 2, 1998, Pages 144-147

  Witzel Schlömp, Konstanze ^a   Hobart, Michael J ^b   Fernie, Barbara A ^b   Orren, Ann ^c   Würzner, Reinhard ^d   Rittner, Christian ^a   Kaufmann, Thomas ^a   Schneider, Peter M ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Ethnic origin; Hemolytic activity; Point mutations

Indexed keywords

COMPLEMENT COMPONENT C9;

ARTICLE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; PRIORITY JOURNAL;

COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C9; FEMALE; GENETIC HETEROGENEITY; HETEROZYGOTE; HUMANS; IRELAND; MALE; MENINGITIS, MENINGOCOCCAL; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION;

EID: 0031839875     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050415     Document Type: Article

References (30)

1. Abbott, C., West, L., Povey, S., Jeremiah, S., Murad, Z., DiScipio, R., and Fey, G. The gene for human complement component C9 mapped to chromosome 5 by polymerase chain reaction. Genomics 4: 606-609, 1989
2. Dupuis, M., Peitsch, M.C., Hamann, U., Stanley, K.K., and Tschopp, J. Mutations in the putative lipid-interaction domain of complement C9 result in detective secretion of the functional protein. Mol Immunol 30: 95-100, 1993
3. Fernie, B.A., Orren, A., Sheehan, G., Schlesinger, M., and Hobart, M.J. Molecular bases of C7 deficiency: three different defects. J Immunol 159: 1019-1026, 1997
4. Figueroa, J.E. and Densen, P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4: 359-395, 1991
5. Fukumori, Y., Yoshimura, K., Ohnoki, S., Yamaguchi, H., Akagaki, Y., and Inai, S. A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan. Int Immunol 1: 85-89, 1989
6. Harriman, G.R., Esser, A.F., Podack, A.C., Wunderlich, A.C., Braude, A.I., Lint, T.F., and Curd, J.G. The role of C9 in complement-mediated killing of Neisseria. J Immunol 127: 2386-2390, 1981
7. Harrison, R.A. and Lachmann, P.J. Complement technology. In D.M. Weir (ed.): Handbook of Experimental Immunology (4th edn). p. 39, Blackwell, Oxford, 1986
8. Hatanaka, M., Seya, T., Inai, S., and Shimizu, A. The functions of the ninth component of human complement are sustained by disulfide bonds with different susceptibilities to reduction. Biochim Biophys Acta 1209: 117-122, 1994
9. Hayama, K., Sugai, N., Tanaka, S., Lee, S., Kikuchi, H., Ito, J., Suzuki, J., Nagata, Y., Kondo, H., Harayama, O., Tuzuki, K., Yoshida, S., Fujita, M., Ohmori, F., Kawai, T., Akagaki, Y., and Inai, S. High-incidence of C9-deficiency throughout Japan: there are no significant differences in incidence among eight areas of Japan. Int Arch Allergy Appl Immunol 90: 400-404, 1989
10. Hobart, M.J., Fernie, B.A., Würzner, R., Oldroyd, R.G., Joysey, V., and Lachmann, P.J. Difficulties in the ascertainment of C9 deficiency: lessons to be drawn from a compound heterozygote C9-deficient subject. Clin Exp Immunol 108: 500-506, 1997
11. Kaufmann, T., Hänsch, G., Rittner, C., Späth, P., Tedesco, F., and Schneider, P.M. Genetic basis of human complement C8β deficiency. J Immunol 150: 4943-4947, 1993
12. Kontermann, R., Deppisch, R., and Rauterberg, E.W. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules. Eur J Immunol 20: 623-628, 1990
13. Lachmann, P.J., Hobart, M.J., and Woo, P. Combined genetic deficiency of C6 and C7 in man. Clin Exp Immunol 33: 193, 1978
14. Lengweiler, S., Schaller, J., and Rickli, E.E. Identification of disulfide bonds in the ninth component (C9) of human complement. FEBS Lett 380: 8-12, 1996
15. Marazziti, D., Eggertsen, G., Fey, G.H., and Stanley, K.K. Relationships between the gene and protein structure in human complement component C9. Biochemistry 27: 6529-6534, 1988
16. Nagata, M., Hara, T., Aoki, T., Mizuno, Y., Akeda, H., Inaba, S., Tsumoto, K., and Ueda, K. Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis. J Pediatr 114: 260-264, 1989
17. Nishizaka, H., Horiuchi, T., Zhu, Z.-B., Fukumori, Y., and Volanakis, J.E. Genetic bases of human complement C7 deficiency. J Immunol 150: 4239-4243, 1996
18. Orren, A., Würzner, R., Potter, P.C., Fernie, B.A., Coetzee, S., Morgan, B.P., and Lachmann, P.J. Properties of a low molecular weight complement component C6 found in human subjects with subtotal C6 deficiency. Immunology 75: 10-16, 1992
19. Peitsch, M.C., Amiguet, P., Guy, R., Brunner, J., Maizel, Jr. J.V., and Tschopp, J. Localization and molecular modeling of the membrane-inserted domain of the ninth component of human complement and perform. Mol Immunol 7: 589-602, 1990
20. Plumb, M.E. and Sodetz, J.M. Proteins of the membrane attack complex. In J.E. Volanakis and M.M. Frank (eds): The Human Complement System in Health and Disease, pp. 119-148, Dekker. New York, 1998
21. Rogne, S., Myklebost, O., Stanley, K., and van Kessel, A.G. The gene for human complement C9 is on chromosome 5. Genomics 5: 149-152, 1989
22. Saucedo, L., Ackermann, L., Platonov, A.E., Gewurz, A., Rakita, R.M., and Densen, P. Delineation of additional genetic bases for C8β deficiency: prevalence of null alleles and predominance of C>T transition in their genesis. J Immunol 155: 5022-5028, 1995
23. Stanley, K.K., Kocher, H.-P., Luzio, J.P., Jackson, P., and Tschopp, J. The sequence and topology of human complement component C9. EMBO J 4: 375-382, 1985
24. Stolfi, R.L. Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system. J Immunol 100: 46-54, 1968
25. Witzel-Schlömp, K., Späth, P.J., Hobart, M.J., Fernie, B.A., Rittner, C., Kaufmann, T., and Schneider, P.M. The human complement C9 gene: identification of two mutations leading to deficiency and revision of the gene structure. J Immunol 158: 5043-5049, 1997
26. Würzner, R., Schulze, M., Happe, L., Franzke, A., Bieber, F.A., Oppermann, M., and Götze, O. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies. Complement Inflamm 8: 328-340, 1991a
27. Würzner, R., Orren, A., Potter, P., Morgan, B.P., Ponard, D., Späth, P., Brai, M., Schulze, M., Happe, L., and Götze, O. Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals. Clin Exp Immunol 83: 430-437, 1991b
28. Würzner, R., Hobart, M.J., Fernie, B.A., Mewar, D., Potter, P.C., Orren, A., and Lachmann, P.J. Molecular basis of subtotal complement deficiency. A carboxy-terminally truncated but functionally active C6. J Clin Invest 95: 1877-1883, 1995
29. Würzner, R., Platonov, A.E., Beloborodov, V.B., Pereverzev, A.I., Vershinina, I.V., Fernie, B.A., Hobart, M.J., Lachmann, P.J., and Orren, A. How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion. Immunology 88: 407-411, 1996
30. Zoppi, M., Weiss, M., Nydegger, U.E., Hess, T., and Späth, P.J. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe. Arch Intern Med 150: 2395-2399, 1990